TY - JOUR
T1 - Outcome at 4.5 years of children born after expectant management of early-onset hypertensive disorders of pregnancy
AU - van Wassenaer, A.G.
AU - Westera, J.
AU - van Schie, P.E.M.
AU - Houtzager, B.A.
AU - Cranendonk, A.
AU - de Groot, L.
AU - Ganzevoort, W.
AU - Wolf, H
AU - de Vries, J.I.P.
PY - 2011
Y1 - 2011
N2 - Objective: The objective of the study was to describe neurodevelopmental outcome at the age of 4.5 years in 216 children, born after expectant management of severe early-onset hypertensive complications of pregnancy. Study Design: This was a prospective follow-up study until age 4.5 years from maternal admission onward. Developmental outcome measurements included child intelligence quotient and behavioral, motor, and neurological outcome. Abnormal composite outcome (perinatal mortality or abnormal developmental outcome) was studied in relation to gestational age (GA), birthweight (BW), and perinatal variables. Results: Fetal and neonatal mortality was 9% and 8%, respectively. Of the 178 survivors, 149 (84%) were seen for follow-up. Mean GA was 31.4 weeks and 90% were born growth restricted. Abnormal developmental outcome occurred in 20% and abnormal composite outcome in 37%. Conclusion: Perinatal mortality or abnormal child development occurs in one third of pregnancies with early-onset and severe hypertensive complications and is highest in the lowest GA and BW ranges. © 2011 Mosby, Inc.
AB - Objective: The objective of the study was to describe neurodevelopmental outcome at the age of 4.5 years in 216 children, born after expectant management of severe early-onset hypertensive complications of pregnancy. Study Design: This was a prospective follow-up study until age 4.5 years from maternal admission onward. Developmental outcome measurements included child intelligence quotient and behavioral, motor, and neurological outcome. Abnormal composite outcome (perinatal mortality or abnormal developmental outcome) was studied in relation to gestational age (GA), birthweight (BW), and perinatal variables. Results: Fetal and neonatal mortality was 9% and 8%, respectively. Of the 178 survivors, 149 (84%) were seen for follow-up. Mean GA was 31.4 weeks and 90% were born growth restricted. Abnormal developmental outcome occurred in 20% and abnormal composite outcome in 37%. Conclusion: Perinatal mortality or abnormal child development occurs in one third of pregnancies with early-onset and severe hypertensive complications and is highest in the lowest GA and BW ranges. © 2011 Mosby, Inc.
UR - https://www.scopus.com/pages/publications/79958100226
UR - https://www.scopus.com/inward/citedby.url?scp=79958100226&partnerID=8YFLogxK
U2 - 10.1016/j.ajog.2011.02.032
DO - 10.1016/j.ajog.2011.02.032
M3 - Article
SN - 0002-9378
VL - 204
JO - American Journal of Obstetrics & Gynecology
JF - American Journal of Obstetrics & Gynecology
IS - 6
M1 - 510.e1
ER -